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Summary 
BACKGROUND: Nutritional factors play an important 
role in the regulation of blood pressure and in the de-
velopment of hypertension. In this analysis, we ex-
plored the associations of 24-hour urinary Na+, K+ and 
urea excretion with blood pressure levels and the risk of 
hypertension in the Swiss population, taking regional 
linguistic differences into account. 
METHODS: The Swiss Survey on Salt is a population 
based cross-sectional study that included 1336 subjects 
from the three main linguistic regions (French, German 
and Italian) of Switzerland. Blood pressure was meas-
ured with a validated oscillometric Omron HEM 907 
device. Hypertension was defined as current antihyper-
tensive treatment or a mean systolic blood pressure 
>140 mm Hg and/or diastolic >90 mm Hg, based on 
eight blood pressure measurements performed at two 
visits. Na+, K+ and urea excretion were assessed in 24-
hour urine collections. We use multiple logistic/linear 
regressions to explore the associations of urine Na+, K+ 
and urea with blood pressure / hypertension, taking into 
account potential confounders and effect modifiers. 
RESULTS: The prevalence of hypertension was 30%, 
26% and 17% in the German-, French- and Italian- 
speaking regions respectively, (p-value across regions 
<0.001). In the Swiss adult population, besides age, sex, 
and body mass index, urinary Na+ excretion was posi-
tively associated with systolic blood pressure and hy-
pertension. Urinary K+ excretion tended to be negatively 
associated with blood pressure but this was not signifi-
cant (p = 0.08). Hypertensive people had a higher 24-
hour urinary Na+/K+ ratio than normotensive people (p = 
0.003). Urinary urea excretion was associated with nei-
ther blood pressure nor hypertension. Participants from 
the German-speaking region had a higher likelihood of 
having a high systolic blood pressure. 
CONCLUSIONS: We confirm a high prevalence of ele-
vated blood pressure in Swiss adults, including regional 
differences. In Switzerland, urinary Na+ excretion is 
associated positively with blood pressure and hyperten-
sion, independently of urinary K+ and urea excretion. 
The observed differences in blood pressure levels 
across linguistic regions are independent of the urinary 
Na+, K+ and urea excretion. 
Key words: nutrition; sodium; potassium; proteins; 
hypertension; population 
Introduction 
Among the many physiological and pathogenic factors that 
participate in the regulation of blood pressure and contribute 
to the development of hypertension, nutritional factors have 
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been shown to play an important role. Indeed, a high salt 
intake [1], moderate but sustained alcohol consumption [2], 
and overweight and obesity [3] are clearly associated with 
higher blood pressure in epidemiological surveys. In contrast, 
high intakes of potassium [1], magnesium and calcium, as well 
as of fibre and protein were found to be inversely associated 
with blood pressure in observational studies [4–6]. Although 
several of these associations are well established, some re-
main unclear, for example the role of protein intake on blood 
pressure and the risk of developing hypertension [5, 7]. Inter-
ventional studies on nutrition have also demonstrated fa-
vourable blood pressure effects of modifying dietary patterns, 
essentially of reducing sodium and increasing intake of potas-
sium, unsaturated fats and protein [8–12]. Therefore, most 
international hypertension guidelines have introduced these 
nonpharmacological interventions as the first step in the 
management of newly diagnosed hypertensive patients [13–
15]. 
Dietary patterns may vary considerably between populations. 
Indeed, the quality of food intake is subject to many influ-
ences, including the availability of healthy food products, 
regional dietary habits, social environment and, of course, the 
local cost of food. Thus, salt intake has recently been shown to 
vary markedly between regions of the world: in some coun-
tries individuals consume on average more than 20 g 
NaCl/day, whereas in others it may be well below 10 g 
NaCl/day [16]. Similarly, potassium intake is highly heteroge-
neous among populations, with a rather low intake in Asian 
populations, probably because the main component of the 
Asiatic diet(white rice) has very low potassium content (be-
tween 10 and 110 mg K+/100 g) [16]. Therefore, the regional 
patterns of food intake might have an impact on population 
blood pressure levels and on the risk of developing hyperten-
sion. In this context, we explored the associations of 24-hour 
urinary Na+, K+ and urea excretion with the blood pressure 
level and the risk of hypertension in the Swiss population, 
taking into account the three linguistic regions of Switzerland 
with their specific food habits: the German, French and Italian 
regions. 
Subjects and methods 
The Swiss Survey on Salt is a cross-sectional population-based 
survey conducted in 9 out of 26 cantons (Vaud, Geneva, Valais, 
Fribourg, Luzern, Basel, Zürich, St Gallen and Ticino), which 
covered the three main linguistic regions of Switzerland. This 
survey was part of a nationwide programme of the Swiss 
Federal Office of Public Health that aimed at reducing salt 
intake in the population. To be included, participants had to 
be permanent residents of Switzerland and aged 15 years or 
older. Recruitment took place from January 2010 to March 
2012 and was based on a two-level sampling strategy similar to 
the one used for the Swiss Health National Surveys conducted 
every five years [17]. The Swiss Statistical Office provided a list 
of randomly selected households from the Swisscom fixed-
line phone directory, which is updated every 3 months, sepa-
rately for each canton. (Swisscom is a major telecommunica-
tion provider in Switzerland, mainly owned by the Swiss 
state.) This directory is the largest and most complete directo-
ry of the country and covers the majority of Swiss households.  
In a first step, we contacted these households by sending an 
information letter followed by phone calls with a maximum 
of three attempts on different days. In a second step, we ran-
domly selected, during the phone call, one person from the 
household to take part in the study, using a computer-
generated random number. We recruited participants in eight 
predefined sex- and age-strata (men and women aged 15–29, 
30–44, 45–59 and ≥60 years). Because of difficulties to recruit 
young and middle-aged people, limited convenience sampling 
was used in selected centres. Two hundred and seventy-seven 
participants out of 1515 who completed the survey (18%) were 
recruited by convenience sampling (primarily using leaflets 
targeting secondary or professional schools or universities). 
Overall participation rate was 10%. This means that we could 
include one participant in 10% of the contacted households. 
Compared with the overall population, subjects from the 
Italian region were slightly overrepresented in order to have a 
clinically relevant number of results. 
Data collection 
The study was conducted for the primary purpose of estimat-
ing dietary salt intake and hypertension prevalence in the 
Swiss adult population. Participants were told that the study 
was about “lifestyle and blood pressure” and specific care was 
taken not to mention salt intake at the time of enrolment, to 
avoid a change in dietary habits before urine collection. The 
study participants attended the study centre on two occa-
sions: one baseline visit before and one follow-up visit after 
completion of the urine collection (within 24 hours). 
Trained healthcare professionals collected data. At the base-
line visit, participants filled in a questionnaire about socio-
demographic factors, medical history, lifestyle and medica-
tion. Questions about alcohol intake were asked, including 
units of wine, beer and spirits consumed in the past 7 days. A 
standard unit was defined as a glass of wine, a bottle of beer or 
a shot of spirits, approximating 10–12 g ethanol [18]. We classi-
fied participants into three mutually exclusive categories 
according to the total number of alcohol units reported in the 
past 7 days (0, 1–6, ≥7 units per week). Smoking status was 
classified as current smoker versus nonsmoker. 
Weight was measured in light indoor clothing to the nearest 
100 g with a medical scale and height was measured to the 
nearest centimetre with a wall-mounted stadiometer. Body 
mass index (BMI) was calculated as weight divided by height 
in metres squared. Overweight was defined as BMI ≤25 kg/m2 
and <30 kg/m2, and obesity as BMI ≥30 kg/m2. Blood pressure 
was measured five times at each visit in the left arm after at 
least 5 minutes rest in the seated position, with a clinically 
validated automated oscillometric device (Omron® HEM-907, 
Matsusaka, Japan) with a standard cuff, or a large cuff if arm 
circumference was ≥33 cm [19]. The average of eight blood 
pressure readings (the second to fourth reading at each visit) 
was used for analysis. Hypertension was defined as mean 
systolic blood pressure ≥140 mm Hg or mean diastolic blood 
pressure ≥90 mm Hg or use of antihypertensive medication. 
Participants were given two 3-litre plastic bottles and standard 
instructions on how to collect a 24-hour urine specimen. 
When brought back at the second visit, urine was weighed, 
mixed, sampled in small aliquots and immediately frozen 
(−20°C) at each study centre. During the second visit an op-
tional nonfasting blood sample was collected. Urine and blood 
samples were subsequently sent to the Central Chemical 
Laboratory of Lausanne University Hospital (CHUV, Lausanne, 
Vaud, Switzerland) for centralised analyses with use of stand-
ard methods and stringent internal quality controls. This 
Central Chemical Laboratory is ISO/CEI 17025 and ISO 15189 
accredited and is regularly checked by the "Centre Suisse de 
Contrôle de Qualité" (CSCQ – Swiss Centre for Quality Control). 
Original article  Swiss Med Wkly. 2017;147:w14411 
Swiss Medical Weekly · PDF of the online version · www.smw.ch   Page 3 of 9 
Published under the copyright license "Attribution - Non-Commercial - No Derivatives 4.0".  
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html. 
Plasma and urinary electrolytes were measured by means of 
indirect potentiometry; urine urea was measured with the 
urease-GLDH method and serum and urinary creatinine with 
the Jaffé kinetic compensated method. We measured Na+ 
excretion in 24-hour urine and used the following conversion 
factor to estimate 24-hour urinary salt excretion: 1 mmol of 
Na+ corresponds to 0.0584 g of salt (NaCl). Protein intake was 
estimated by using the Maroni formula [20], based on meas-
ured 24-hour urinary urea excretion, a method considered as a 
valid biomarker [21, 22]. Twenty-four-hour urinary K+ excre-
tion was used to estimate dietary K+ intake [23]. The estimated 
glomerular filtration rate (eGFR) was calculated using the 
Chronic Kidney Disease-Epidemiology Collaboration (CKD-
EPI) formula. 
The quality of 24-hour urine collections was verified from the 
urinary creatinine excretion adapted for sex and weight. The 
reproducibility of urinary Na+ excretion was verified in a small 
subset of participants (n = 57) who made two collections. The 
coefficient of correlation between the two collections was 0.69 
for Na+ excretion and 0.71 for urinary volume. For the analysis, 
97 subjects were excluded because of incomplete urine collec-
tion. Criteria for exclusion were: a urinary volume less than 
300 ml/24 h (n = 3), participants reporting not having collect-
ed all 24-hour urine (n = 29) and a urinary creatinine excretion 
equal to or below the sex-specific fifth percentile: 0.121 
mmol/kg/24 h in men and 0.082 mmol/kg/24 h in women (n = 
77). 
Participants answered the following questions at the end of 
the visit: 
‒ “Do you consider that a diet rich in salt has an impact on 
your health” (possible answers: yes, no, do not know); 
‒ “According to you, for which diseases is there a direct link 
with salt intake?” (arterial hypertension, cardiac diseases, 
diabetes, irritable bowel syndrome, no disease, over-
weight/obesity, myocardial infarction, stroke, tuberculosis, 
other);  
‒ “Which type of salt do you use at home?” (salt without 
supplements, iodised salt, salt enriched with iodine and 
fluoride, spicy salt, do not know);  
‒ “Do you usually try to limit your dietary salt intake?” 
(yes/no);  
‒ “Are you usually interested in your daily dietary salt in-
take?” (yes/no);  
‒ “What is the maximum amount of salt a Swiss adult should 
eat on a daily basis?” (5 g, 7.5 g, 10 g, 15 g, do not know); 
‒ “Do you usually add salt to your meals at home / outside of 
home?” (always, usually, occasionally, rarely); 
‒ “Rank the following items with respect to their salt con-
tent, taking portion size into account” (one tea spoon of 
dressing sauce [15 g], one medium-sized bowl of soup [300 
ml], one medium-sized slice of bread [30 g], one tea spoon 
of Knorr Aromat [19 g]);  
‒ “What is the main source of salt in the daily diet of a stand-
ard person living in Switzerland?” (salt added to the meal at 
the table, fast foods or processed meals, mineral waters, 
breads, meat and cold cuts, cheeses, soups, do not know). 
Ethics 
The ethics committee of each centre approved the study. 
Every participant gave written informed consent; for partici-
pants under the age of 18, the written informed consent of a 
parent was also obtained. Each participant received compen-
sation of 20 Swiss Francs (about 20 Euros or US dollars) upon 
completion of the study. 
Statistical analyses 
Sample size calculation was based on the primary outcome of 
interest, namely dietary salt intake, aiming at being able to 
detect (with 80% power at a 5% two-sided type 1 error rate) a 
10% difference in salt intake in each sex strata, in the four 
prespecified age groups (15–29 years, 30–44 years, 45–59 years, 
≥60 years) and in the two larger linguistic regions (German vs 
French). Mean and standard deviation were used to describe 
unadjusted continuous variables, and percentages to describe 
dichotomous or categorical variables. Prevalence was de-
scribed proportions across sex and age groups. Analysis of 
variance (ANOVA) and the chi-squared test were used to com-
pare the characteristics of groups where appropriate. Multiple 
logistic regression was conducted with hypertension as the 
dependent variable, including linguistic region, age, sex, 
smoking status, alcohol consumption, BMI, eGFR, serum urea, 
serum uric acid, serum Na+, serum K+, corrected serum Ca++, 
urinary excretion (Na+, K+, urea, creatinine) and urine volume. 
Multiple linear regression was conducted with systolic blood 
pressure as the dependent variable, including linguistic re-
gion, age, sex, smoking status, alcohol consumption, BMI, 
eGFR, serum urea, serum uric acid, serum Na+, serum K+, uri-
nary excretion (Na+, K+, urea, creatinine) and urinary volume. 
To ease interpretation of the findings, sex-specific tertiles of 
serum and urine Na+, K+ and urea were used instead of contin-
uous covariates. For both models, a backward procedure was 
used, starting with a full model, and then removing, one at a 
time, nonsignificant covariates. Age, sex, BMI, urine volume 
and duration of urine collection as well as urinary creatinine 
excretion were forced into the models. The choice of covari-
ates was based on clinical knowledge and previous research, as 
well as an interest in exploring the available nutrition bi-
omarkers. A nonparametric test was used to assess trend 
(nptrend function in Stata) across sex-specific quintiles of 
systolic blood pressure. 
Results 
The characteristics of the 1336 subjects enrolled in the survey 
are shown, by linguistic region, in table 1 . The prevalence of 
hypertension was 30%, 25% and 17% in the German-, French- 
and Italian-speaking regions, respectively (p-value for differ-
ences across regions <0.001). Hypertension prevalence by sex 
and age groups is presented in figure 1.  
 
 
 
Figure 1: Hypertension prevalence by sex and age groups. 
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Table 1: Participants’ characteristics by linguistic region (n = 1336). 
 German French Italian p-value 
No. 709 428 199  
Age (years) 48.8 (18) 47.8 (18.1) 45.3 (18.4) 0.06 
Sex (% women) 0.51 (0.5) 0.52 (0.5) 0.51 (0.5) 0.92 
Current smoking (%) 0.29 (0.45) 0.3 (0.46) 0.26 (0.44) 0.40 
Regular alcohol 
consumption (%) 
0.84 (0.36) 0.86 (0.35) 0.78 (0.42) 0.04 
Education level (%)*    0.02 
 Basic 13.8 16.8 18.6  
 Intermediate 42.9 43.7 51.3  
 High 43.3 39.5 30.1  
BMI (kg/m2) 25.3 (4.3) 25.5 (5.1) 24.5 (4.2) 0.03 
Hypertension (%) 0.30 (0.46) 0.26 (0.44) 0.17 (0.38) 0.001 
SBP (mm Hg) 126.1 (15.9) 122.5 (14.9) 120.5 (15) <0.001 
DBP (mm Hg) 75.5 (10.2) 74.2 (9.8) 69.9 (9.9) <0.001 
Serum Na+ (mmol/l) 141.7 (1.9) 142.0 (2.1) 142.2 (1.9) <0.001 
Serum K+ (mmol/l) 4.25 (0.45) 4.12 (0.34) 4.05 (0.31) <0.001 
Corrected serum 
Ca++ (mmol/l) 
2.3 (0.09) 2.28 (0.12) 2.28 (0.09) <0.001 
Serum urea (mmol/l) 5.4 (1.77) 5.6 (2.07) 5.8 (1.71) 0.02 
Serum uric acid 
(μmol/l) 
305 (82) 309 (90) 293 (80) 0.08 
Serum creatinine 
(μmol/l) 
80 (16.9) 79 (19.3) 80 (16.3) 0.50 
eGFR† 
(ml/min/1.73m2) 
89 (19.5) 91 (19) 91 (20.1) 0.13 
Urine volume 
(ml/1440 min) 
2139 (943) 1747 (796) 1668 (805) <0.001 
Urine creatinine 
(mg/kg/24 h) 
19.0 (5) 19.1 (5.1) 20.1 (5.7) 0.03 
Urine Na+ 
(mmol/1440 min) 
160 (66) 151 (71) 158 (72) 0.09 
Urine K+ (mmol/1440 
min) 
68.0 (24.8) 65.7 (24.1) 63.3 (27.3) 0.05 
Urine Ca++ 
(mmol/1440 min) 
4.0 (2.34) 4.21 (2.5) 4.18 (2.57) 0.25 
Urine urea 
(mmol/1440 min) 
362 (136) 371 (146) 387 (152) 0.12 
BMI = body mass index; DBP = diastolic blood pressure; eGFR = estimated 
glomerular filtration rate; SBP = systolic blood pressure 
Data are means (standard deviation) unless specified otherwise. 
* Basic = mandatory school or less; intermediate = apprenticeship or high 
school; high = higher specialized education or university. 
† Based on Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI) 
equation. 
 
Note the very high prevalence in men and women aged ≥60 
years (65 and 54%, respectively). Several other differences 
were observed across linguistic regions: the level of education 
was lower in Italian-speaking subjects; systolic and diastolic 
blood pressure, urinary volume, serum potassium and urinary 
potassium excretion were higher in German-speaking partici-
pants. Urinary salt excretion was 7.2 ± 3.1, 8.1 ± 3.4 and 7.6 ± 3.2 
g/24 h in women and 10.3 ± 4.3, 10.7 ± 4.1 and 10.5 ± 4.3 g/24 h 
in men from the French-, German- and Italian-speaking re-
gions, respectively. 
Nutritional factors and their association with blood 
pressure 
Table 2 shows the results of the multiple linear regressions for 
systolic blood pressure in the entire set of subjects. As ex-
pected, age, sex, BMI and smoking were significantly associat-
ed with blood pressure. In addition, a high education level was 
associated with a lower blood pressure. Systolic blood pres-
sure was significantly higher in participants from the German-
speaking area than in those from the French- and Italian-
speaking regions.  
Table 2: Multiple linear regression for systolic blood pressure (n = 1336). 
Variables Beta coefficient 
95% confi-
dence limits 
p-value 
Age (years) 0.37 0.31; 0.44 <0.001 
Sex (men vs women) −9.53 −11.46; −7.6 <0.001 
Language French ref.   
German 2.91 1.34; 4.47 <0.001 
Italian −0.86 −2.98; 1.26 0.43 
Current smoking (yes/no) −1.63 −3.15; −0.1 0.04 
Antihypertensive treatment 
(yes/no) 
4.12 2.02; 6.21 <0.001 
Body mass index (kg/m2) 0.33 0.13; 0.53 <0.001 
Alcohol 
consumption 
<1 unit/week ref.   
<1 unit/day 
and >1 
unit/week 
0.56 −1.13; 2.24 0.52 
≥1 unit/day 0.57 −1.52; 2.65 0.60 
Education Basic ref.   
Medium level −2.3 −4.29; −0.32 0.02 
High level −3.5 −5.55; −1.45 0.001 
Serum uric 
acid  
Tertile 1* ref.   
Tertile 2 0.88 −0.78; 2.53 0.30 
Tertile 3 1.86 0.04; 3.68 0.05 
Serum urea 
(mmol/l) 
Tertile 1 ref.   
Tertile 2 −1 −2.75; 0.74 0.26 
Tertile 3 −1.35 −3.38; 0.68 0.19 
Estimated 
protein intake 
Tertile 1 ref.   
Tertile 2 −0.52 −2.41; 1.38 0.59 
Tertile 3 −0.03 −2.46; 2.4 0.98 
Serum Ca++ Tertile 1 ref.   
Tertile 2 0.23 −1.42; 1.89 0.78 
Tertile 3 0.96 −0.76; 2.68 0.27 
Urine Ca++ Tertile 1 ref.   
Tertile 2 2.01 0.28; 3.74 0.02 
Tertile 3 1.11 −0.78; 3 0.25 
Serum Na+ Tertile 1 ref.   
Tertile 2 0.4 −1.34; 2.13 0.65 
Tertile 3 0.88 −0.74; 2.5 0.29 
Urine Na+ Tertile 1 ref.   
Tertile 2 0.45 −1.28; 2.18 0.61 
Tertile 3 2.81 0.81; 4.81 0.01 
Serum K+ Tertile 1 ref.   
Tertile 2 −0.89 −2.47; 0.69 0.27 
Tertile 3 −0.99 −2.73; 0.75 0.27 
Urine K+ Tertile 1 ref.   
Tertile 2 −0.84 −2.62; 0.95 0.36 
Tertile 3 −1.89 −3.98; 0.19 0.08 
Urine volume (ml/24 h) 0.54 −0.32; 1.4 0.22 
Urine creatinine (mg/kg/24 h) 0.06 −0.16; 0.29 0.59 
The p-values from the likelihood ratio test are: p = 0.0001 for linguistic region; 
p = 0.004 for education level; p = 0.07 for urine Ca++ tertiles; p = 0.01 for urine 
Na+ tertiles; p = 0.08 for urine K+ tertiles; p >0.10 for tertiles of serum Ca++, K+, 
Na+, uric acid and urea, for alcohol consumption and estimated protein intake. 
 
Serum sodium, potassium and urea were not associated with 
blood pressure levels but participants in the highest tertile of 
serum uric acid had a higher systolic blood pressure. Urinary 
Na+ excretion was associated positively with systolic blood 
pressure. An inverse trend was observed with urinary K+ ex-
cretion but the association did not reach statistical signifi-
cance. In the fully adjusted model, the association was border-
line significant (p = 0.08) (fig. 2). Urinary urea excretion was 
not associated with systolic blood pressure. The associations 
between the various clinical and nutritional factors and sex-
specific quintiles of systolic blood pressure are presented in 
supplementary table S1 (appendix). Note that the urinary 
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Na+/K+ ratio was strongly associated with systolic blood pres-
sure.  
 
 
 
Figure 2: Adjusted systolic blood pressure (mm Hg) by sex-specific tertiles of 
24-hour urinary K+ (left) or Na+ (right) excretion. Fully adjusted models include 
age, sex, linguistic region, smoking, antihypertensive treatment, body mass 
index, alcohol consumption, education, sex-specific serum uric acid, urea, Na+, 
K+ and Ca++ tertiles, sex-specific 24-hour urinary urea, Ca++, Na+ and K+ 
excretion tertiles, 24-hour urine volume and urinary creatinine excretion per kg 
body weight. The p-values are from a test for linearity across tertiles in the 
corresponding model, coding tertiles using 1, 2 and 3. For 24-hour urinary Na+, 
tertiles 1 (n = 437), 2 (n = 449) and 3 (n = 450) correspond to 93, 148 and 228 
mmol, respectively. For 24-hour urinary K+, tertiles 1 (n = 435), 2 (n = 459) and 
3 (n =4 42) correspond to 43, 65 and 92 mmol, respectively. 
Nutritional factors and their association with hyper-
tension 
In our population, the overall prevalence of hypertension was 
32.3% in men and 25.6% in women. In men, the regional preva-
lence was 27.9%, 36.8% and 23.8% in the French, German and 
Italian regions respectively. For women, these figures were 
18.1%, 21.4% and 12.6% respectively. Table 3 shows the multiple 
logistic regressions for hypertension in the entire population. 
Age, sex, BMI and urinary Na+ excretion were positively asso-
ciated with hypertension. Serum uric acid was positively 
associated with hypertension, but a negative association was 
found between serum potassium and hypertension. Urinary 
K+ and urea excretion (estimated protein intake) and linguistic 
region were not independently associated with hypertension. 
Unadjusted selected clinical characteristics of normotensive 
and hypertensive participants and age-, sex-, BMI- and linguis-
tic region-adjusted means of plasma and urinary electrolytes 
in normotensive subjects are described in table S2 (appendix). 
Hypertensive patients were older, more frequently men, 
smokers and overweight. They also presented higher serum 
uric acid and lower urinary K+ excretion. There was no differ-
ence in urinary Na+ excretion between hypertensive and 
normotensive participants, but the Na+/K+ ratio was higher in 
hypertensive participants. 
 
Table 3: Multivariable logistic regression for hypertension (n = 1336). 
Variables Odds ratio 95% confi-dence 
limits 
p-value 
Age (years) 1.09 1.07; 1.11 <0.001 
Sex (men vs women) 0.32 0.19; 0.52 <0.001 
Education level Basic 1   
Intermediate 0.86 0.54; 1.38 0.53 
High 0.82 0.5; 1.34 0.44 
Language French 1   
German 1.26 0.86; 1.84 0.23 
Italian 0.72 0.42; 1.24 0.24 
Current smoking (yes/no) 0.72 0.51; 1.03 0.08 
Alcohol consump-
tion 
<1 unit /week 1   
<1 unit/day 
and >1 
unit/week 
0.97 0.63; 1.47 0.88 
≥1 unit/day 0.91 0.55; 1.49 0.7 
Body mass index (kg/m2) 1.14 1.09; 1.19 <0.001 
eGFR (ml/min/1.73 m2) 1 0.99; 1.02 0.54 
Serum uric acid Tertile 1 1   
Tertile 2 1.37 0.89; 2.1 0.15 
Tertile 3 1.79 1.16; 2.78 0.01 
Serum urea  
(mmol/l) 
Tertile 1 1   
Tertile 2 0.77 0.49; 1.20 0.24 
Tertile 3 0.81 0.49; 1.34 0.41 
Estimated protein 
intake 
Tertile 1 1   
Tertile 2 0.83 0.53; 1.32 0.44 
Tertile 3 0.79 0.44; 1.42 0.43 
Serum Ca++ Tertile 1 1   
Tertile 2 1.01 0.67; 1.54 0.95 
Tertile 3 1.84 1.22; 2.78 0.004 
Urine Ca++  
(mmol/24 h) 
Tertile 1 1   
Tertile 2 0.78 0.51; 1.18 0.24 
Tertile 3 0.76 0.49; 1.19 0.23 
Serum K+ Tertile 1 1   
Tertile 2 0.58 0.39; 0.86 0.01 
Tertile 3 0.58 0.38; 0.88 0.01 
Urine K+  
(mmol/24 h)  
Tertile 1 1   
Tertile 2 1.13 0.73; 1.76 0.58 
Tertile 3 0.88 0.53; 1.44 0.60 
Serum Na+  Tertile 1 1   
Tertile 2 0.9 0.59; 1.39 0.64 
Tertile 3 0.76 0.51; 1.13 0.18 
Urine Na+  
(mmol/24 h)  
Tertile 1 1   
Tertile 2 1.33 0.87; 2.03 0.19 
Tertile 3 1.99 1.23; 3.23 0.01 
Urine volume (ml/24 h) 0.99 0.80; 1.23 0.95 
Urine creatinine (mg/kg/24 h) 0.96 0.90; 1.01 0.14 
eGFR = estimated glomerular filtration rate (Chronic Kidney Disease-
Epidemiology Collaboration formula) 
All tertiles are sex-specific (i.e., they were generated separately for women 
and for men). 
The p-values from the likelihood ratio test are: p = 0.09 for linguistic region; p 
= 0.03 for serum uric acid tertiles; p = 0.003 for serum Ca++ tertiles; p = 0.03 
for serum urea tertiles; p = 0.01 for serum K+ tertiles; p = 0.02 for urine Na+ 
tertiles; p >0.10 for serum Na+ tertiles, urine K+ tertiles, urine Ca++ tertiles, 
education level, reported alcohol consumption and estimated protein intake. 
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When questioned on the effect of salt on health, participants 
from the German-speaking region were less aware of the 
impact of salt on blood pressure (77.3% in the German vs 
84.9% in the French and 88.0% in Italian part of Switzerland) 
and cardiovascular complications than participants from 
other regions (p <0.01). Participants from the German-
speaking region reported less frequently the use of salt with-
out supplements (30.6%, p<0.05), but more frequently use of 
salt with iodine (42.4% vs 29% in French and 27.3% in Italian 
speaking participants, p<0.001) or spicy salt (46.9% vs 26.3% in 
French and 21.8% in Italian participants, p<0.001). They were 
also less inclined to try to limit the quantity of salt in their 
diet (54.2% in German-speaking subjects vs 61.4% and 66.8% in 
French- and Italian-speaking subjects, respectively). 
Discussion 
The main goal of this study was to assess the association of 
several dietary factors with blood pressure and hypertension 
in Switzerland, a country of 8 million inhabitants with three 
main linguistic areas that have specific dietary habits but a 
relatively comparable standard of living and economic status. 
The data obtained in these analyses first tend to confirm the 
prominent roles of age, sex, BMI and sodium and potassium 
intake on blood pressure and hypertension. They also confirm 
the association between serum uric acid and hypertension. 
Globally, we did not find any association between protein 
intake and blood pressure or hypertension. We also observed 
regional differences that were independent of the explored 
dietary factors. 
Dietary factors and blood pressure 
Among all components of a normal diet, sodium is certainly 
the most important factor because of its crucial physiological 
role in the regulation of blood volume and blood pressure. 
Large epidemiological surveys have reported an association 
between urinary sodium excretion, as an indirect marker of 
sodium intake, and blood pressure [24, 25]. This association 
was confirmed recently with the data of the Prospective Urban 
Rural Epidemiology study (PURE) in which 102 216 adults from 
18 countries were investigated. Indeed, the authors found an 
increase of 2.11 mm Hg in systolic and 0.78 mm Hg in diastolic 
blood pressure for each 1-g increment in estimated sodium 
excretion [1]. In this latter study, the slope of association was 
steeper in hypertensive individuals and in subjects older than 
55 years. In accordance with these observations, we also found 
a significant association between urinary sodium excretion 
and systolic blood pressure in Swiss participants. 
The role of potassium in the regulation of blood pressure and 
in the development of hypertension has long been underes-
timated. However, several studies compiled in a meta-analysis 
published as long ago as 1997 had found that a low potassium 
intake plays an important role in the genesis of high blood 
pressure [26]. In this meta-analysis, potassium supplementa-
tion had a favourable impact on blood pressure, particularly in 
studies in which participants were concurrently exposed to a 
high sodium intake. More recent data have demonstrated that 
an increased potassium intake can not only reduce blood 
pressure in people with hypertension, but also reduce the risk 
of stroke [27]. In a recent large Chinese survey, a higher con-
sumption of fresh fruit was associated with a lower blood 
pressure and a reduced prevalence of cardiovascular compli-
cations and mortality [6]. A post-hoc analysis of the ONTAR-
GET and TRANSCEND studies has even suggested that a high 
potassium intake may actually retard the progression of 
chronic kidney diseases [28]. In the PURE study, urinary potas-
sium excretion was also inversely correlated with blood pres-
sure and the slope of the association was again steeper in 
older and in hypertensive subjects [1]. Moreover, the influence 
of potassium on blood pressure was greater in subjects with a 
high sodium intake. In our population, urinary potassium 
excretion was indeed negatively associated with blood pres-
sure, but the association did not reach statistical significance. 
However, systolic blood pressure was not associated with 
urinary potassium excretion unless urinary sodium excretion 
was included in the model. In that case, systolic blood pres-
sure was lower in the highest tertile of potassium excretion (p 
= 0.08). These results further suggest a strong interaction 
between sodium and potassium intake and blood pressure, 
the impact of the former being in part dependent on the back-
ground intake of the latter. In that respect, one could question 
whether the assessment of the urinary Na+/K+ ratio, which 
includes both factors, would not be a better index than either 
sodium or potassium alone in the evaluation of blood pres-
sure outcomes and incident hypertension. Indeed, studies 
have suggested that the Na+/K+ ratio correlates better with 
blood pressure than urinary sodium alone [29–31], and several 
authors have proposed increasing potassium intake in addi-
tion to a moderate reduction of sodium intake to lower blood 
pressure (reviewed recently by Perez and Chang [32]). In our 
study, the urinary Na+/K+ ratio was indeed better correlated 
with sex-specific quintiles of systolic blood pressure than was 
urinary sodium excretion alone, as presented in table S1. 
Among the other dietary parameters investigated in our 
study, protein intake was not associated with systolic or dias-
tolic blood pressure. 
Dietary factors and hypertension 
In epidemiological surveys, a high urinary sodium excretion is 
associated with hypertension. In our multivariable logistic 
regression for hypertension, urinary sodium excretion (be-
sides age, sex and BMI) was positively associated with hyper-
tension. A negative association was found with serum potas-
sium but not urinary potassium excretion. However, when 
the clinical characteristics of hypertensive subjects in our 
population were compared with those of the normotensive 
subjects, a greater age, a greater proportion of men and a 
higher BMI characterised hypertensive subjects. Interestingly, 
urinary sodium excretion was comparable in normotensive 
and hypertensive subjects, but the urinary excretion of potas-
sium and urea were significantly lower in hypertensive sub-
jects. The Na+/K+ ratio was also higher in hypertensive than in 
normotensive subjects in our population. These observations 
are in accordance with previous publications suggesting that a 
low potassium intake [27] and a low protein intake are associ-
ated with a higher blood pressure and hypertension [7, 10, 33]. 
The precise mechanisms whereby protein intake influences 
blood pressure and the risk of hypertension are not complete-
ly understood. However, a secondary analysis of the PREMIER 
trial, a randomised clinical trial designed to determine the 
effect of two multicomponent lifestyle interventions on blood 
pressure [34], have suggested that an increased intake of plant 
protein rather than animal proteins may have a favourable 
effect in lowering blood pressure and preventing the devel-
opment of hypertension [35]. 
The higher systolic blood pressure levels observed in the 
German-speaking region compared with the other linguistic 
regions was independent of 24-hour urinary sodium, potassi-
um and urea excretion, which suggests that a factor other 
than salt, potassium and protein intake contributed to the 
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higher prevalence of hypertension in the German-speaking 
participants. Studies on the regional disparities in elevated 
blood pressure prevalence in the United States have shown 
that many factors other than salt and potassium intake may 
play a role, including the intake of riboflavin, niacin, iron and 
vitamins A, C and B6 [36]. Moreover, the environment, socio-
economic status, educational level and, of course, the genetics 
of the population may play an important role in the develop-
ment of hypertension [37] An additional factor may be the 
perception of the role of dietary factors in causing hyperten-
sion and cardiovascular complications, which may have an 
impact on attitudes to prevention within the populations. 
Thus, in the 2007 Swiss Health Survey, which enrolled 17 879 
subjects in seven administrative regions of Switzerland [17], 
cardiovascular risk factor screening and management differed 
between regions and the differences could not be accounted 
for by differences in population age, gender, educational level 
or migrant status, suggesting that other factors such as local 
habits might be at stake. In this survey, the prevalence of 
hypertension was higher in some areas of the German region, 
but detection and management was comparable in all regions. 
The detection and treatment of dyslipidaemia and diabetes 
was significantly lower in German-speaking regions than in 
the French- and Italian-speaking areas. However, there was no 
direct measurement of blood pressure, glucose or lipids in this 
survey and the presence of hypertension, diabetes and 
dyslipidaemia was based on a positive response to the ques-
tion "Did a doctor or a healthcare professional tell you that 
you have high blood pressure, diabetes or a high cholesterol?" 
A recent publication by Chammartin et al. demonstrated that 
cardiovascular mortality is higher in the German-speaking 
areas of Switzerland than in the French- and Italian-speaking 
cantons [38]. This observation would fit with our findings, as 
blood pressure and hypertension are major determinants of 
cardiovascular morbidity and mortality. 
The following limitations have to be taken into account in the 
interpretation of this study. First, this was a cross-sectional 
study, which precludes inference of causality. Second, the low 
participation rate limits the external validity of our findings. 
The low participation rate in this study may be explained by 
the unattractiveness of 24-hour urine collection and the two-
stage sampling strategy, which reflects that fact that the per-
son contacted by phone was not automatically the one ran-
domly selected to enter the study. It is, however, unlikely that 
the observed relationships would be substantially different in 
nonparticipants. Dietary information was not collected via a 
standardised and detailed food-frequency questionnaire, 
which may result in incomplete and/or imprecise dietary 
information. 
In conclusion, salt intake is high in the three linguistic regions 
of Switzerland but it is comparable to that of most central 
European countries. Our data confirm the important influ-
ence of sodium intake on blood pressure and the prevalence 
of hypertension in the Swiss context. We observed higher 
blood pressure levels in the German-speaking region, even 
after taking urinary sodium, potassium and urea excretion 
into account, which suggests that other factors, possibly die-
tary as well, are needed to fully explain regional differences in 
blood pressure. 
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Appendix: Supplementary tables 
Table S1: Participants’ characteristics by sex-specific quintiles of systolic blood pressure (n = 1336). 
Covariate Q1 (n = 265) 
Q2 
(n = 262) 
Q3 
(n = 268) 
Q4 
(n = 269) 
Q5 
(n = 272) 
p-value  
trend 
Serum Na+ (mmol/l)* 141.8 
(141.6; 142) 
141.9 
(141.7; 142.1) 
141.7 
(141.5; 141.9) 
142 
(141.7; 142.2) 
141.9 
(141.6; 142.2) 
0.45 
Serum K+ (mmol/l)* 4.21 
(4.17; 4.25) 
4.19 
(4.14; 4.23) 
4.17 
(4.12; 4.22) 
4.17 
(4.13; 4.22) 
4.17 
(4.12; 4.22) 
0.23 
Serum Ca++ (corrected) (mmol/l)* 2.29 
(2.28; 2.31) 
2.30 
(2.29; 2.31) 
2.30 
(2.29; 2.31) 
2.31 
(2.30; 2.32) 
2.30 
(2.29; 2.31) 
0.06 
Serum urea (μmol/l)* 5.34 
(5.17; 5.51) 
5.29 
(5.13; 5.45) 
5.23 
(5.06; 5.4) 
5.31 
(5.14; 5.49) 
5.16 
(5; 5.31) 
0.07 
Serum uric acid (μmol/l)* 287 
(280; 294) 
292 
(285; 300) 
293 
(285; 301) 
297 
(290; 305) 
296 
(289; 304) 
0.08 
eGFR (ml/min/1.73 m2) 90.9 
(89.3; 92.6) 
89.2 
(87.6; 90.8) 
89.3 
(87.8; 90.8) 
89.2 
(87.7; 90.7) 
90.9 
(89.4; 92.5) 
0.83 
Urine Na+ (mmol/24 h)* 143 
(136; 150) 
143 
(137; 151) 
152 
(144; 159) 
155 
(148; 162) 
154 
(148; 161) 
0.003 
Urine K+ (mmol/24 h)* 63.3 
(60.7; 66) 
64.9 
(62.1; 67.8) 
65.8 
(63.2; 68.4) 
64.2 
(61.6; 66.8) 
62.8 
(60.2; 65.5) 
0.63 
Urine Na+/K+ ratio 2.32 
(2.21; 2.44) 
2.27 
(2.16; 2.38) 
2.36 
(2.24; 2.47) 
2.48 
(2.38; 2.59) 
2.53 
(2.42; 2.65) 
<0.001 
Urine urea (mmol/24 h)* 345 
(332; 358) 
353 
(340; 367) 
361 
(348; 375) 
361 
(348; 375) 
354 
(341; 367) 
0.29 
Urine Ca++ (mmol/24 h)* 3.55 
(3.31; 3.79) 
3.70 
(3.45; 3.97) 
3.77 
(3.51; 4.03) 
3.84 
(3.58; 4.11) 
3.86 
(3.59; 4.14) 
0.05 
Urine volume (l/24 h)* 1.78 
(1.68; 1.88) 
1.84 
(1.74; 1.94) 
1.83 
(1.74; 1.93) 
1.90 
(1.81; 2.00) 
1.87 
(1.77; 1.97) 
0.22 
Urine creatinine (mg/kg/24 h)* 18.4 
(17.9; 18.9) 
18.9 
(18.4; 19.4) 
19 
(18.6; 19.4) 
19.2 
(18.7; 19.7) 
18.7 
(18.3; 19.2) 
0.56 
eGFR = estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration formula); Q = quintile 
Data are adjusted means and 95% confidence limits. Means are adjusted for age, sex, body mass index and linguistic region. 
 
Table S2: Selected characteristics of normotensive and hypertensive participants. 
 Normotension 
(n = 981) 
Hypertension 
(n = 355)  
 Mean (SE) Mean (SE) p-value
* 
Age (years) 42.33 (0.52) 63.63 (0.7) <0.001 
Sex (proportion women) 0.57 0.37 <0.001 
Current smoking (%) 26 36 <0.001 
Body weight (kg) 70.8 (0.5) 80.4 (0.9) <0.001 
Body height (cm) 170.4 (0.3) 169. 5 (0.5) 0.11 
BMI (kg/m2) 24.3 (0.13) 27.9 (0.25) <0.001 
Age-, sex-, BMI- and linguistic region-adjusted means (95% confidence limits) 
Serum Na+ (mmol/l) 141.9 (141.8; 142.1) 141.6 (141.4; 141.9) 0.007 
Serum K+ (mmol/l) 4.19 (4.17; 4.21) 4.16 (4.11; 4.2) 0.14 
Serum Ca++ (corrected) (mmol/l) 2.3 (2.29; 2.3) 2.31 (2.3; 2.32) 0.12 
Serum urea (μmol/l) 5.27 (5.19; 5.36) 5.24 (5.08; 5.4) 0.71 
Serum uric acid (μmol/l) 290 (287; 294) 301 (295; 309) 0.004 
eGFR (ml/min/1.73m2) 89.9 (89.1; 90.7) 90 (88.6; 91.5) 0.85 
Urine Na+ (mmol/24 h) 149 (145; 158) 151 (145; 158) 0.51 
Urine K+ (mmol/24 h) 65.2 (63.8; 63.7) 61.4 (59.2; 63.7) 0.005 
Urine Na+/K+ ratio 2.35 (2.29; 2.62) 2.52 (2.43; 2.62) 0.003 
Urine urea (mmol/24 h) 359 (353; 354) 343 (331; 354) 0.01 
Urine volume (ml/24 h) 1.86 (1.81; 1.88) 1.80 (1.72; 1.88) 0.24 
Urine creatinine (mg/kg/24 h) 19 (18.8; 18.8) 18.4 (18; 18.8) 0.02 
eGFR = estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration formula) 
Data are unadjusted means (standard error) in the upper part and age-, sex-, BMI- and linguistic region-adjusted means in the lower part. 
* p-values from t test, chi-squared test or Wald test as appropriate. 
 
